MicroRNA-19b functions as potential anti-thrombotic protector in patients with unstable angina by targeting tissue factor (Q28115561)

coagulation factor VII

1 reference

Tumor necrosis factor

1 reference

serine-type endopeptidase activity

1 reference

1 reference

1 reference

Sufang Li

1

1 reference

3 January 2017

Jingyi Ren

2

1 reference

3 January 2017

Ning Xu

3

1 reference

3 January 2017

Jing Zhang

4

1 reference

3 January 2017

Qiang Geng

5

1 reference

3 January 2017

Chengfu Cao

6

1 reference

3 January 2017

Chongyou Lee

7

1 reference

3 January 2017

Junxian Song

8

1 reference

3 January 2017

Jingjin Li

9

1 reference

3 January 2017

Hong Chen

Journal of Molecular and Cellular Cardiology

10

1 reference

3 January 2017

1 October 2014

1 reference

3 January 2017

1 reference

3 January 2017

75

1 reference

3 January 2017

49–57

1 reference

3 January 2017

Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.06.017

From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.06.017

Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.06.017

Plaque instability frequently occurs days or weeks before occlusive coronary thrombosis: a pathological thrombectomy study in primary percutaneous coronary intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.06.017

Platelet activation and atherothrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.06.017

Mechanisms of thrombus formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.06.017

Hypercoagulable states in cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.06.017

The coagulation cascade: initiation, maintenance, and regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.06.017

Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.06.017

Mechanisms of acute coronary syndromes and their implications for therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.06.017

Celecoxib decreases endothelial tissue factor expression through inhibition of c-Jun terminal NH2 kinase phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.06.017

MicroRNAs: target recognition and regulatory functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.06.017

Repression of protein synthesis by miRNAs: how many mechanisms?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.06.017

MicroRNAs in vascular and metabolic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.06.017

Emerging role of microRNAs in cardiovascular biology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.06.017

Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.06.017

Circulating microRNAs are new and sensitive biomarkers of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.06.017

Circulating microRNAs in patients with coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.06.017

Microparticles, vascular function, and atherothrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.06.017

Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.06.017

Platelets amplify inflammation in arthritis via collagen-dependent microparticle production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.06.017

Microparticles: major transport vehicles for distinct microRNAs in circulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.06.017

Cellular Origins and Thrombogenic Activity of Microparticles Isolated From Human Atherosclerotic Plaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.06.017

The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.06.017

Identification of miRNAs as potential modulators of tissue factor expression in patients with systemic lupus erythematosus and antiphospholipid syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.06.017

Involvement of miR-30c and miR-301a in immediate induction of plasminogen activator inhibitor-1 by placental growth factor in human pulmonary endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.06.017

Susceptibility to chronic thromboembolic pulmonary hypertension may be conferred by miR-759 via its targeted interaction with polymorphic fibrinogen alpha gene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.06.017

ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.06.017

Dynamic release and clearance of circulating microparticles during cardiac stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.06.017

Formation, recognition and bioactivities of a novel G-quadruplex in the STAT3 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.06.017

Microvesicles as cell-cell messengers in cardiovascular diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.06.017

Circulating microRNAs: biomarkers or mediators of cardiovascular diseases?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.06.017

Pre-analytical and analytical issues in the analysis of blood microparticles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.06.017

Regulation of fibrinogen production by microRNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.06.017

The hemostatic system as a modulator of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.06.017

Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.06.017

MicroRNA-19 (miR-19) regulates tissue factor expression in breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.06.017

MicroRNA-19a targets tissue factor to inhibit colon cancer cells migration and invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2014.06.017

10.1016/J.YJMCC.2014.06.017

7 January 2021

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

2016419

2016419

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference